These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29685610)

  • 1. Review of the evidence on handling drugs and hazardous products in Urology Departments. Consensus document between the Spanish Urological Association and the Spanish Society of Hospital Pharmacy.
    Unda-Urzaiz M; Alonso-Herreros JM; Fernandez-Gomez JM; Gaspar-Carreño M; Cozar-Olmos JM; Lleti ACC;
    Actas Urol Esp (Engl Ed); 2018; 42(6):375-380. PubMed ID: 29685610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists.
    Unda-Urzáiz M; Alonso-Herreros JM; Fernández-Gómez JM; Gaspar-Carreño M; Cozar-Olmos JM; Cercós Lleti AC
    Farm Hosp; 2018 Sep; 42(5):212-215. PubMed ID: 30173640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
    Valero-García S; González-Haba E; Gorgas-Torner MQ; Alonso-Herreros JM; Cercós Lletí AC; Poveda-Andrés JL; Calleja-Hernandez MÁ; Delgado-Sánchez O
    Farm Hosp; 2021 Mar; 45(2):96-107. PubMed ID: 33709894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish adaptation of the recommendations for the appropriate use of social networks in urology of the European Association of Urology.
    Rodríguez-Socarrás ME; Gómez-Rivas J; Álvarez-Maestro M; Tortolero L; Ribal MJ; Garcia Sanz M; Roupret M
    Actas Urol Esp; 2016 Sep; 40(7):417-23. PubMed ID: 26850338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on safe handling of hazardous drugs: the advice of experts.
    Power LA; Anderson RW; Cortopassi R; Gera JR; Lewis RM
    Am J Hosp Pharm; 1990 May; 47(5):1050-60. PubMed ID: 2186622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer programs used in the field of hospital pharmacy for the management of dangerous drugs: systematic review of literature.
    Climent-Ballester S; García-Salom P; Sanz-Valero J
    Front Public Health; 2023; 11():1233264. PubMed ID: 37711235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to assess the hazardous exposure potential of investigational drugs.
    McLeod EN; Fillis CJ; Blind JE
    Am J Health Syst Pharm; 2020 Apr; 77(9):697-700. PubMed ID: 34278414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measures of preventing occupational exposure to hazardous drugs-based on new insights].
    Sugiura S; Gohma H; Hamajima N
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):923-5. PubMed ID: 25132022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texas passes first law for safe patient handling in America: landmark legislation protects health-care workers and patients from injury related to manual patient lifting.
    Hudson MA
    J Long Term Eff Med Implants; 2005; 15(5):559-66. PubMed ID: 16218903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a safety program for handling hazardous drugs in a community hospital.
    Massoomi FF; Neff B; Pick A; Danekas P
    Am J Health Syst Pharm; 2008 May; 65(9):861-5. PubMed ID: 18436733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complying with workers' right-to-know legislation.
    Knoeck MJ; Wadd WB; Giese RM
    Am J Hosp Pharm; 1985 Sep; 42(9):1974-6. PubMed ID: 4050815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus to identify the dangerous drugs risks in hospital pharmacy services.
    Bernabeu-Martínez MÁ; García-Salom P; Burgos-San José A; Navarro-Ruiz A; Sanz-Valero J; Wanden-Berghe C
    Farm Hosp; 2020 Mar; 44(2):51-61. PubMed ID: 32452316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the new handling recommendations for hazardous drugs in a hospital pharmacy service.
    García-Alcántara BG; Perelló Alomar C; Moreno Centeno E; Modamio P; Mariño EL; Delgado Sánchez O
    Farm Hosp; 2017 Mar; 41(2):257-269. PubMed ID: 28236800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration.
    López CV; Quito GLR
    Int J Pharm Compd; 2022; 26(5):358-362. PubMed ID: 36053761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations.
    Fuentes-Irigoyen R; Martín de Rosales Cabrera AM; Riestra AC; Vila MN; Dávila-Pousa C; Alonso Herreros JM; López-Cabezas C; Cañete C; Pernía-López MS; Garcia-Palomo M; Arriola Villalobos P; Ibares-Frías L; Urcelay Segura JL; Yañez Martínez JR
    Farm Hosp; 2018 Mar; 42(2):82-88. PubMed ID: 29501060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative Review of Clinical Guidelines for Medical and Surgical Management of Urolithiasis: Consensus and Controversy 2020.
    Jiang P; Xie L; Arada R; Patel RM; Landman J; Clayman RV
    J Urol; 2021 Apr; 205(4):999-1008. PubMed ID: 33284671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey of safe handling of hazardous drugs in hospital settings: Use of an innovative approach.
    Pinet E; Langlais A; Chouinard A; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Dec; 30(8):1385-1396. PubMed ID: 37997344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish urological schools (1880-1970).
    Pérez-Albacete M
    Actas Urol Esp (Engl Ed); 2018 Nov; 42(9):586-592. PubMed ID: 29759881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin.
    Kohjimoto Y; Kusumoto H; Nishizawa S; Kikkawa K; Kodama Y; Ko M; Matsumura N; Hara I
    Int J Urol; 2014 Dec; 21(12):1201-7. PubMed ID: 25074295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.